Can common diabetes drugs help protect hearts and kidneys?
NCT ID NCT07237451
Summary
This study aims to understand how a class of drugs called SGLT2 inhibitors affects the long-term health of people who have both chronic kidney disease and a specific type of heart failure (HFpEF). Researchers will observe 200 patients, some taking the drug and some not, to see if it helps prevent major heart and kidney problems or death. The goal is to gather real-world evidence on whether these drugs offer protective benefits for this high-risk patient group.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART FAILURE PRESERVED EJECTION FRACTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Dr. C.I. Parhon Hospital in Iasi
RECRUITINGIași, Romania
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.